Fioricet with Codeine (APAP 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule
- RxCUI
- 1433802
- RxNorm name
- Fioricet with Codeine (APAP 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule
- Display name
- Fioricet with Codeine (APAP 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule
- Full name
- Fioricet with Codeine (APAP 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fioricet with Codeine | BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE | Actavis Pharma, Inc. | df9801fc-03fe-41da-a6b3-0f76788217c9 | 2021-03-01 | Boxed warning, Warnings, Adverse reactions | 1433802 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| df9801fc-03fe-41da-a6b3-0f76788217c9 | Fioricet with Codeine 50 MG / 300 MG / 40 MG / 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Fioricet with Codeine] [SBD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [Fioricet with Codeine] [SY] · Fioricet with Codeine (APAP 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule [SY] | 4 | 11 | These highlights do not include all the information needed to use FIORICET with CODEINE safely and effectively. See full prescribing information for FIORICET with CODEINE. FIORICET ® with CODEINE (butalbital, acetaminophen, caffeine, and codeine phosphate) Capsules, for oral use, CIII Initial U.S. Approval: 1992 | 20210301 |